These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8149659)

  • 1. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions.
    Ettehadi P; Greaves MW; Wallach D; Aderka D; Camp RD
    Clin Exp Immunol; 1994 Apr; 96(1):146-51. PubMed ID: 8149659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.
    Kristensen M; Chu CQ; Eedy DJ; Feldmann M; Brennan FM; Breathnach SM
    Clin Exp Immunol; 1993 Nov; 94(2):354-62. PubMed ID: 8222328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of cytokines on psoriatic skin grafted on nude mice: involvement of the tumour necrosis factor (TNF) receptor.
    Gilhar A; David M; Kalish RS; Weisinger G
    Clin Exp Immunol; 1996 Oct; 106(1):134-42. PubMed ID: 8870711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis.
    Takematsu H; Ohta H; Tagami H
    Arch Dermatol Res; 1989; 281(6):398-400. PubMed ID: 2596867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in skin lesions of psoriasis.
    Gearing AJ; Fincham NJ; Bird CR; Wadhwa M; Meager A; Cartwright JE; Camp RD
    Cytokine; 1990 Jan; 2(1):68-75. PubMed ID: 2104215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
    Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
    Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha.
    Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM
    Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-γ in psoriatic patients.
    Rasheed H; El-Komy M; Hegazy RA; Gawdat HI; AlOrbani AM; Shaker OG
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):764-768. PubMed ID: 27496874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.
    Kawaguchi M; Mitsuhashi Y; Kondo S
    Br J Dermatol; 2005 May; 152(5):915-9. PubMed ID: 15888146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picea mariana polyphenolic extract inhibits phlogogenic mediators produced by TNF-α-activated psoriatic keratinocytes: Impact on NF-κB pathway.
    García-Pérez ME; Allaeys I; Rusu D; Pouliot R; Janezic TS; Poubelle PE
    J Ethnopharmacol; 2014; 151(1):265-78. PubMed ID: 24189030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
    Armstrong L; Foley NM; Millar AB
    Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCP-1 in psoriatic patients: effect of biological therapy.
    Lembo S; Capasso R; Balato A; Cirillo T; Flora F; Zappia V; Balato N; Ingrosso D; Ayala F
    J Dermatolog Treat; 2014 Feb; 25(1):83-6. PubMed ID: 23480385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
    Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM
    J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.